Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-263400
Filing Date
2024-11-21
Accepted
2024-11-21 16:07:57
Documents
1
Group Members
FFI III S.A.R.L.FYI S.A.R.L.OLIFANT LUXCO S.A.R.L.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d874622dsc13da.htm SC 13D/A 103667
  Complete submission text file 0001193125-24-263400.txt   105393
Mailing Address 888 BOYLSTON STREET SUITE 1500 BOSTON MA 02199
Business Address 888 BOYLSTON STREET SUITE 1500 BOSTON MA 02199 617-497-3500
Bracebridge Capital, LLC (Filed by) CIK: 0001426486 (see all company filings)

EIN.: 043344637 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Subject) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1227
Type: SC 13D/A | Act: 34 | File No.: 005-87833 | Film No.: 241484299
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)